The Efficacy and Safety Study of 2107 Injection in Subjects With Mild to Moderate Knee Osteoarthritis

by | Aug 6, 2026 | Clinical Trials | 0 comments

​ Conditions: Mild Knee Osteoarthritis; Moderate Knee Osteoarthritis

Interventions: Device: 2107 Injection; Device: DUROLANE®

Sponsors: BioRegen Biomedical (Changzhou) Co., Ltd

Not yet recruiting Conditions: Mild Knee Osteoarthritis; Moderate Knee Osteoarthritis
Interventions: Device: 2107 Injection; Device: DUROLANE®
Sponsors: BioRegen Biomedical (Changzhou) Co., Ltd
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *